Filing Details
BeOne Medicines Ltd. (NASDAQ:ONC) filed a Form 8-K with the Securities and Exchange Commission on June 26, 2026, disclosing a material event.
8k filedNASDAQ:ONC
BeOne Medicines Ltd. (ONC) Reports Material Event to SEC
Filing Details BeOne Medicines Ltd. (NASDAQ:ONC) filed a Form 8-K with the Securities and Exchange Commission on June 26, 2026, disclosing a material event. Market Context BeOne…
Market Context
BeOne Medicines Ltd.'s stock currently trades at $279.89 with a market capitalization of $34.2B. The Healthcare company's stock moved following the disclosure.
8-K filings report material events that shareholders should know about between regular quarterly or annual reports. These can include leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance. The specific nature of the event determines its significance for BeOne Medicines Ltd.'s stock.
All SEC filings for BeOne Medicines Ltd. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View ONC Stock Page
Frequently Asked Questions
Where can I read ONC's SEC filings?
Browse all filings on our ONC SEC filings page.
What types of SEC filings does BeOne Medicines Ltd. file?
Public companies like BeOne Medicines Ltd. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.